Point72 Asset Management L.P. 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 06:11 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management L.P. | 209,971 0.200% |
-4,323,785 (-95.37%) |
Filing |
| 2023-04-05 4:23 pm Purchase |
2023-04-04 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management L.P. | 4,533,756 5.000% |
2,095,618 (+85.95%) |
Filing |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management L.P. | 2,438,138 4.200% |
-1,032,140 (-29.74%) |
Filing |
| 2022-08-23 4:59 pm Purchase |
2022-08-22 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management L.P. | 3,470,278 5.200% |
3,470,278 (New Position) |
Filing |